Several studies report that fermented foods have positive effects on the gut microbiota and reduce inflammation, a major risk factor for all chronic diseases.
Age is an important risk factor for all chronic diseases, implying that finding ways to slow down aging could simultaneously delay the onset of all these diseases and significantly improve healthy life expectancy.
The results of clinical studies on new anti-obesity drugs confirm that significant body weight loss is associated with a reduced risk of cardiovascular disease.
High consumption of certain emulsifiers widely used in the manufacture of ultra-processed foods is associated with an increased risk of cardiovascular disease.
One study reports that people who have cardiovascular disease are at much higher risk of developing several types of cancers in the years that follow.
Akkermansia muciniphila, a bacterium that colonizes the mucus layer of the intestinal wall, contributes to the maintenance of this protective layer and generates metabolites that have several beneficial effects on metabolism and immunity.
Initially developed to treat patients with type 2 diabetes, these drugs also cause significant weight loss and are establishing themselves as the first truly effective pharmacological treatments for obesity.
